ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Mediar Therapeutics
The Clinical Program Lead drives clinical development programs from inception to regulatory submission, partnering with stakeholders to ensure successful trial execution. This role involves overseeing program operations, managing CROs and vendors, and providing expert input on regulatory submissions while mentoring the clinical operations team.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2019
Mediar Therapeutics is a clinical-stage biotech focused on developing therapies to halt and reverse fibrosis by targeting the myofibroblast—the cell that deposits collagen and sustains the pro‑fibrotic microenvironment. The company pursues unexplored, mechanism-driven targets and is running clinical studies in multiple fibrosing diseases to translate those insights into new treatment options. Mediar’s approach centers on deactivating myofibroblasts to slow, and potentially reverse, fibrotic progression for patients and caregivers.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Mediar Therapeutics.
Mediar Therapeutics didn’t post a salary, so this is our estimate from similar listings.